India  

Covid-19: Vaccine makers asked to submit more data

IndiaTimes Wednesday, 9 December 2020
The drug regulator has asked Bharat Biotech and Serum Institute of India (SII), which have sought emergency use authorisation (EUA) for their anti-Covid vaccines, to submit updated safety and immunogenicity data from Phase-3 trials being held in India, official sources said.
0
shares
ShareTweetSavePostSend
 
Video Credit: Wochit Business - Published
News video: Pfizer COVID-19 Vaccine Offers Protection Within 10 Days Of Being Vaccinated

Pfizer COVID-19 Vaccine Offers Protection Within 10 Days Of Being Vaccinated 00:32

Pfizer's COVID-19 vaccine confers more than 50% protection against the virus within 10 days of receiving the first dose. Pfizer, which developed the vaccine with BioNTech, said the vaccine was more than 95% after 2 doses. The two vaccine doses are intended to be administered 21 days apart. According...

💡 newsR Knowledge: Other News Mentions

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Watch: India sends SII's Covishield vaccines to Mauritius, Seychelles, Myanmar [Video]

Watch: India sends SII's Covishield vaccines to Mauritius, Seychelles, Myanmar

India dispatched consignments of SII's Covishield to Myanmar, Seychelles and Mauritius. India is sending Covid-19 vaccines as part of donation program to neighbours and key partners. Bhutan, Maldives, Bangladesh, Nepal were also part of India's initial rollout of vaccines. In addition, India plans to supply vaccine doses to Afghanistan and Sri Lanka. Covishield's commercial supplies to countries having agreements with SII have also begun. Two flights are slated to carry two million doses each to Brazil and Morocco on Friday. India is carrying out vaccine diplomacy under its 'Neighbourhood First' policy. Last week, India launched the world's biggest Covid-19 vaccination drive across the country.

Credit: HT Digital Content    Duration: 02:46Published

India to send SII's COVID-19 vaccine 'Covishield' to Myanmar, Seychelles, Mauritius

The Ministry of External Affairs had announced a vaccine rollout for Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday.
DNA
COVID vaccine ready for dispatch to Myanmar, Seychelles, Mauritius from Mumbai airport [Video]

COVID vaccine ready for dispatch to Myanmar, Seychelles, Mauritius from Mumbai airport

Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 22. The consignment containing COVID-19 vaccine will be dispatched to Myanmar, Seychelles and Mauritius.

Credit: ANI    Duration: 01:17Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Covaxin led to tolerable safety outcomes & enhanced immune responses, says Lancet

Even as a controversy rages over the safety of India’s first indigenous Covid-19 vaccine Covaxin after it was granted Emergency Use Authorisation (EUA) even as..
IndiaTimes

Not in favour of granting extra chance to UPSC aspirants who missed exam due to Covid: Centre to SC

The Centre on Friday told the Supreme Court that it was not in favour of granting one more opportunity to those civil services aspirants who could not appear in..
IndiaTimes
COVID-19: Over 10 lakh beneficiaries vaccinated in India [Video]

COVID-19: Over 10 lakh beneficiaries vaccinated in India

A total of 10,43,534 beneficiaries have been vaccinated in India for COVID-19. India reported 14,545 new COVID-19 cases and 18,002 discharges on January 22. With new infections, the COVID tally of the country stood at 1,06,25,428. Which includes 1,88,688 active cases. 1,02,83,708 patients have been discharged across the country. With 163 deaths in the last 24 hours, the death toll rose to 1,53,032.

Credit: ANI    Duration: 01:28Published

Covid-19: India records 14,545 new cases

India's Covid-19 caseload rose to 1,06,25,428 with 14,545 people testing positive for coronavirus infection in a day, while the recoveries have surged to..
IndiaTimes

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai [Video]

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase. The mega COVID-19 vaccination drive began in India on January 16 (Saturday).

Credit: ANI    Duration: 01:28Published

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against..
IndiaTimes
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

Emergency Use Authorization

U.S. FDA authorizes second COVID-19 vaccine [Video]

U.S. FDA authorizes second COVID-19 vaccine

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 311,000 lives lost. Gavino Garay reports.

Credit: Reuters - Politics    Duration: 00:45Published
U.S. FDA authorizes second vaccine [Video]

U.S. FDA authorizes second vaccine

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 311,000 lives lost. Gavino Garay reports.

Credit: Reuters - Politics    Duration: 00:45Published
2nd COVID-19 vaccine set for OK in US with FDA panel endorsement [Video]

2nd COVID-19 vaccine set for OK in US with FDA panel endorsement

The FDA's Vaccines and Related Biological Products Advisory Committee has recommended the Emergency Use Authorization (EUA) to a COVID-19 vaccine made by Moderna.

Credit: ABC Action News    Duration: 02:04Published
FDA to vote on EUA for Pfizer's COVID-19 vaccine [Video]

FDA to vote on EUA for Pfizer's COVID-19 vaccine

19 vaccine candidate items.[0].image.alt A generic image of a needle and medication. By: Justin BoggsPosted at 7:09 PM, Dec 09, 2020 and last updated 1:19 PM, Dec 10, 2020 The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee is currently holding a meeting to consider Pfizer’s coronavirus vaccine, which has already gotten authorization from officials in Canada and the UK.

Credit: ABC Action News    Duration: 02:00Published

You Might Like


Related videos from verified sources

Hillsdale Hospital allows limited visits based on new COVID-19 data [Video]

Hillsdale Hospital allows limited visits based on new COVID-19 data

Hillsdale Hospital patients can now have one guest visit them after new COVID-19 data suggests things are trending in the right direction. Health officials continue to monitor trends daily.

Credit: FOX 47 News Michigan     Duration: 01:46Published
Hillsdale Hospital allows visitors based on trending Covid data, but on very limited basis [Video]

Hillsdale Hospital allows visitors based on trending Covid data, but on very limited basis

Hillsdale Hospital announced that patients can now have one guest visit them after new Covid-19 data suggests things are trending in the right direction. Health officials continue to monitor trends..

Credit: FOX 47 News Michigan     Duration: 02:30Published
New Year Brings Time to Reflect on Innovation: TrueCar’s Beth Mach [Video]

New Year Brings Time to Reflect on Innovation: TrueCar’s Beth Mach

The pandemic has been a catalyst for innovation as businesses find new ways of doing things to help customers, many of whom are stuck at home and rely more than ever on digital connections with the..

Credit: BeetTV - Affiliate     Duration: 11:26Published

Related news from verified sources

COVID-19 vaccine: Bharat Biotech's Covaxin Phase 1 trial shows it has no serious adverse events

Pain at the injection site was the most common local adverse event and was well tolerated in all dose groups.
DNA Also reported by •IndiaTimesHindu

AIIMS unable to find required number of volunteers for phase-3 trial of Bharat Biotech's Covid vaccine

The AIIMS here is unable to find the required number of volunteers for the phase-3 trial of Bharat Biotech's Covid-19 vaccine, with officials saying people are...
IndiaTimes

Hopeful India will get COVID-19 vaccine nod by Dec end or early Jan: AIIMS Director

Director of the All Indian Institute of Medical Sciences (AIIMS) Dr Randeep Guleria has said that he is hopeful of that by the end of this month or early next...
Mid-Day Also reported by •IndiaTimes